Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Gutierrez-Agüera, Francisco  [Clear All Filters]
2020
Molina O, Vinyoles M, Granada I, Roca-Ho H, Gutierrez-Agüera F, Valledor L, López-López CManuel, Rodríguez-González P, Trincado JLuis, Tirados-Menéndez S, et al. Impaired Condensin Complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL. Blood. 2020.
Petazzi P, Torres-Ruiz R, Fidanza A, Roca-Ho H, Gutierrez-Agüera F, Castaño J, Rodriguez-Perales S, de la Guardia RDíaz, López-Millan B, Bigas A, et al. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells. Mol Ther Nucleic Acids. 2020;20:196-204.
2021
Zanetti SRomina, Velasco-Hernandez T, Gutierrez-Agüera F, Díaz VM, Romecín PAlejandra, Roca-Ho H, Sánchez-Martínez D, Tirado N, Baroni MLibero, Petazzi P, et al. A novel and efficient tandem CD19- and CD22-directed CAR for B-cell ALL. Mol Ther. 2021.
2023
Domínguez F, Lalaguna L, Martínez-Martín I, Piqueras-Flores J, Rasmussen TBloch, Zorio E, Giovinazzo G, Prados B, Ochoa JPablo, Bornstein B, et al. Titin Missense Variants as a Cause of Familial Dilated Cardiomyopathy. Circulation. 2023;147(22):1711-1713.
2024
Velasco-Hernandez T, Trincado JL, Vinyoles M, Closa A, Martinez-Moreno A, Gutierrez-Agüera F, Molina O, Rodríguez-Cortez VC, Ximeno-Parpal P, Fernandez-Fuentes N, et al. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Hemasphere. 2024;8(2):e45.